| Q38784321 | A Single Excitation-Duplexed Imaging Strategy for Profiling Cell Surface Protein-Specific Glycoforms. |
| Q38786094 | A case for protein-level and site-level specificity in glycoproteomic studies of disease |
| Q37986822 | Acute phase glycoproteins: bystanders or participants in carcinogenesis? |
| Q36286726 | An N-glycosylation Analysis of Human Alpha-2-Macroglobulin Using an Integrated Approach |
| Q34489424 | Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2011-2012. |
| Q37714292 | Analysis of glycan variation on glycoproteins from serum by the reverse lectin-based ELISA assay |
| Q51072346 | Analysis of haptoglobin N-glycome alterations in inflammatory and malignant lung diseases by capillary electrophoresis. |
| Q33762901 | Analysis of serum haptoglobin fucosylation in hepatocellular carcinoma and liver cirrhosis of different etiologies |
| Q36651493 | Analytical glycobiology at high sensitivity: current approaches and directions |
| Q35975965 | Characterization of Pharmaceutical IgG and Biosimilars Using Miniaturized Platforms and LC-MS/MS. |
| Q58087849 | Clinical application of quantitative glycomics |
| Q85888507 | Clinical utility of high-throughput glycome analysis in patients with pancreatic cancer |
| Q36904030 | Defining putative glycan cancer biomarkers by MS. |
| Q92534817 | Evaluation of AGP Fucosylation as a Marker for Hepatocellular Carcinoma of Three Different Etiologies |
| Q33649601 | Fucosylation is a promising target for cancer diagnosis and therapy |
| Q36089872 | Glycomic and proteomic profiling of pancreatic cyst fluids identifies hyperfucosylated lactosamines on the N-linked glycans of overexpressed glycoproteins |
| Q48251620 | Glycomic profiling of targeted serum haptoglobin for gastric cancer using nano LC/MS and LC/MS/MS. |
| Q37714287 | Glycoprotein biomarker panel for pancreatic cancer discovered by quantitative proteomics analysis. |
| Q93348073 | Glycoproteomic markers of hepatocellular carcinoma-mass spectrometry based approaches |
| Q36904006 | Identifying cancer biomarkers by mass spectrometry-based glycomics |
| Q92814248 | In-Depth Mapping of the Urinary N-Glycoproteome: Distinct Signatures of ccRCC-related Progression |
| Q38731700 | Insights on N-glycosylation of human haptoglobin and its association with cancers |
| Q42998397 | LC-MS/MS quantitation of esophagus disease blood serum glycoproteins by enrichment with hydrazide chemistry and lectin affinity chromatography |
| Q33671429 | Label-free relative quantification of alpha-2-macroglobulin site-specific core-fucosylation in pancreatic cancer by LC-MS/MS. |
| Q37009594 | N-Glycan profile analysis of transferrin using a microfluidic compact disc and MALDI-MS |
| Q38418322 | N-glycosylation is critical for the stability and intracellular trafficking of glucose transporter GLUT4 |
| Q35874750 | N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients. |
| Q36832494 | Quantitative liquid chromatography-mass spectrometry-multiple reaction monitoring (LC-MS-MRM) analysis of site-specific glycoforms of haptoglobin in liver disease |
| Q37297209 | Recent trends in analytical and structural glycobiology |
| Q40962674 | Reevaluation of Pholiota squarrosa lectin-reactive haptoglobin as a pancreatic cancer biomarker using an improved ELISA system |
| Q28731567 | Semi-automated identification of N-Glycopeptides by hydrophilic interaction chromatography, nano-reverse-phase LC-MS/MS, and glycan database search |
| Q40104458 | Serum N-glycans outperform CA19-9 in diagnosis of extrahepatic cholangiocarcinoma. |
| Q28079101 | Serum glycoprotein-derived N- and O-linked glycans as cancer biomarkers |
| Q40003002 | Site-specific and linkage analyses of fucosylated N-glycans on haptoglobin in sera of patients with various types of cancer: possible implication for the differential diagnosis of cancer. |
| Q36832489 | Site-specific glycoforms of haptoglobin in liver cirrhosis and hepatocellular carcinoma |
| Q36362594 | Smoking and lung cancer-induced changes in N-glycosylation of blood serum proteins |
| Q34320236 | Sub 2-μm macroporous silica particles derivatized for enhanced lectin affinity enrichment of glycoproteins |
| Q92627364 | iTRAQ-based Comparative Serum Proteomic Analysis of Prostate Cancer Patients with or without Bone Metastasis |